Cold & Cough Remedies - Angola

  • Angola
  • In Angola, the revenue in the Cold & Cough Remedies market market reaches US$42.72m in 2024.
  • It is projected that the market will experience an annual growth rate of 6.40% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in this market, amounting to US$11,190.00m in 2024.
  • In terms of per capita figures, the revenue generated per person in Angola in 2024 is US$1.13.
  • Angola's cold and cough remedies market is experiencing a surge in demand due to the country's high prevalence of respiratory infections.

Key regions: United States, Japan, Australia, United Kingdom, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies market in Angola is experiencing steady growth due to increasing customer preferences for over-the-counter remedies, as well as local special circumstances and underlying macroeconomic factors.

Customer preferences:
Angolan customers are increasingly turning to over-the-counter remedies for cold and cough symptoms. This shift in preference can be attributed to several factors. Firstly, there is a growing awareness among consumers about the effectiveness and convenience of these remedies. Over-the-counter products offer quick relief from symptoms and can be easily purchased without a prescription. Additionally, customers prefer the affordability of these remedies compared to prescription medications. This preference for over-the-counter remedies is driving the growth of the Cold & Cough Remedies market in Angola.

Trends in the market:
One of the key trends in the Cold & Cough Remedies market in Angola is the increasing demand for natural and herbal remedies. Customers are becoming more conscious about the ingredients in the products they use and are seeking natural alternatives to traditional medications. This trend is fueled by the perception that natural remedies are safer and have fewer side effects. As a result, companies in the market are introducing new products that cater to this demand, such as herbal cough syrups and natural cold relief tablets.Another trend in the market is the growing popularity of combination products. Customers are looking for remedies that provide relief from multiple symptoms, such as cough, congestion, and sore throat. Combination products that offer a comprehensive solution to cold and cough symptoms are gaining traction in the market. These products often contain a combination of active ingredients that target different symptoms, providing customers with convenience and effectiveness in one package.

Local special circumstances:
Angola's healthcare system is still developing, and access to healthcare facilities and prescription medications can be limited in some areas. This has led to an increased reliance on over-the-counter remedies for minor ailments, including cold and cough symptoms. The availability and affordability of these remedies make them a popular choice among Angolan consumers. Additionally, traditional medicine practices are deeply rooted in Angolan culture, and many customers prefer to use herbal remedies for common ailments.

Underlying macroeconomic factors:
Angola has been experiencing economic growth in recent years, which has contributed to the increasing purchasing power of consumers. As disposable incomes rise, customers are more willing to spend on healthcare products, including Cold & Cough Remedies. The growing middle class in Angola is driving the demand for over-the-counter remedies, as they seek affordable and accessible healthcare solutions. Furthermore, the urbanization and modernization of the country have also played a role in the growth of the Cold & Cough Remedies market, as urban dwellers have easier access to a wider range of products.In conclusion, the Cold & Cough Remedies market in Angola is growing due to customer preferences for over-the-counter remedies, the increasing demand for natural and combination products, local special circumstances such as limited access to healthcare facilities, and underlying macroeconomic factors such as economic growth and urbanization. As the market continues to develop, companies should focus on catering to customer preferences and expanding their product offerings to capitalize on the growing demand.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)